BEYOND AIR INC (XAIR)
US08862L1035 - Common Stock
BEYOND AIR INC
NASDAQ:XAIR (11/22/2024, 8:13:56 PM)
After market: 0.55 +0.01 (+1.85%)0.54
+0.02 (+3.99%)
Company Profile
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in developing a platform for nitric oxide generators and delivery systems. The company is headquartered in Garden City, New York and currently employs 107 full-time employees. The company went IPO on 2019-05-07. The firm has received United States Food and Drug Administration (FDA) approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The company is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19), and nontuberculous mycobacteria (NTM) among others. The company has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder (ASD) and other neurological disorders. Its approved product and active pipeline of product candidates include LungFit PH, LungFit PRO and LungFit GO.
Company Info
BEYOND AIR INC
900 Stewart Avenue, Suite 301
Garden City NEW YORK 11530
P: 15166658200
CEO: Steven Lisi
Employees: 107
Website: https://www.beyondair.net/
XAIR News
9 days ago - Beyond Air™Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare ConferenceGARDEN CITY, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device...
12 days ago - ChartmillWhat's going on in today's pre-market sessionThe US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
12 days ago - ChartmillGet insights into the top gainers and losers of Monday's after-hours session.As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
12 days ago - Beyond Air™Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate UpdateRevenues increased 17% compared to the previous quarter ended June 30, 2024 Strengthened balance sheet is expected to provide sufficient cash runway...
13 days ago - Beyond Air™Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting- LV UNO in combination with anti-rPD-L1 resulted in prolonged survival and doubled the tumor growth inhibition rate in MAT B III tumor bearing rats...
25 days ago - Beyond Air™Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and WebcastGARDEN CITY, N.Y., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device...
XAIR Twits
Here you can normally see the latest stock twits on XAIR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
